{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-065686","form_type":"8-K","ticker":"PFSA","cik":"0001859807","company_name":"Profusa, Inc.","filed_at":"2025-07-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.413418+00:00","generated_at":"2026-05-18T05:49:43.690533+00:00","sec_items":["1.01","2.01","2.03","3.02","9.01","3.03","5.01","5.02","5.06","8.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"NorthView Acquisition Corp closes merger with Profusa, Inc., becoming Profusa, Inc.","bullets":["Profusa valued at $155M; exchange ratio of 0.94 shares of new common stock per Profusa share.","Issued $10M principal PIPE convertible note to Ascent Partners at 10% OID, 18-month maturity.","Founder shares locked up for 8 months; other lock-up periods from 6 to 12 months.","Profusa is a clinical-stage digital health company with CE-marked Lumee Oxygen and Lumee Glucose in trials.","PIPE Investors subject to lock-up and registration rights; security interest granted on assets."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-065686","json":"https://secwatch.observer/filing/0001213900-25-065686.json","markdown":"https://secwatch.observer/filing/0001213900-25-065686.md","text":"https://secwatch.observer/filing/0001213900-25-065686.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1859807/000121390025065686/0001213900-25-065686-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1859807/000121390025065686/ea0249267-8k_profusa.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T05:49:43.690533+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3b77449157a6491ad5aefdf755260f3304cc4041","claim":"Profusa, Inc.: NorthView ceased to be a shell company upon closing of the business combination.","evidence_excerpt":"NorthView ceased to be a shell company upon the Closing.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1859807/000121390025065686/0001213900-25-065686-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"shell status"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}